Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75-Reference-Cited by-同舟云学术

Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75

Published:2022-11 Issue:11 Volume:30 Page:1527-1539.e5
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Cao Yunlong,Song Weiliang,Wang Lei,Liu Pan,Yue Can,Jian Fanchong,Yu Yuanling,Yisimayi Ayijiang,Wang Peng,Wang Yao,Zhu Qianhui,Deng Jie,Fu Wangjun,Yu Lingling,Zhang Na,Wang Jing,Xiao Tianhe,An Ran,Wang Jing,Liu Lu,Yang Sijie,Niu Xiao,Gu Qingqing,Shao Fei,Hao Xiaohua,Meng Bo,Gupta Ravindra Kumar,Jin Ronghua,Wang Youchun,Xie Xiaoliang Sunney,Wang Xiangxi

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference56 articles.

1. Phenix: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr;Adams;D Biol. Crystallogr,2010

2. Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies;Bruel;Nat. Med,2022

3. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells;Cao;Cell,2020

4. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies;Cao;Nature,2022

5. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection;Cao;Nature,2022

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants;Nature Communications;2024-09-04

2. Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope;Signal Transduction and Targeted Therapy;2024-08-28

3. Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission;mBio;2024-08-14

4. Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants;Structure;2024-08

5. An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2;Clinical Microbiology and Infection;2024-08